within Pharmacolibrary.Drugs.B_BloodAndBloodFormingOrgans.B05C_IrrigatingSolutions.B05CB02_SodiumCitrate;

model SodiumCitrate
  extends Pharmacolibrary.Drugs.ATC.B.B05CB02;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>B05CB02</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Sodium citrate is an alkalinizing agent and anticoagulant used mainly to treat metabolic acidosis, as a buffer in various settings, and as an additive to blood products to prevent coagulation by chelating calcium. It is also used as a urine alkalizer and to treat renal tubular acidosis. Sodium citrate is an approved drug and is widely used in medical settings today.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for healthy adults, as literature with precise PK models reporting specific model parameters (such as compartmental volumes and clearance values) is lacking; parameter values are estimated based on known pharmacokinetic behavior of citrate in humans.</p><h4>References</h4><ol><li><p>Nemec, K, et al., &amp; Lemmens-Gruber, R (2010). Evidence-based intravenous pain treatment with analgesic infusion regimens. <i>Arzneimittel-Forschung</i> 60(5) 256–261. DOI:<a href=\"https://doi.org/10.1055/s-0031-1296282\">10.1055/s-0031-1296282</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/20533762/\">https://pubmed.ncbi.nlm.nih.gov/20533762</a></p></li><li><p>Islam, T, &amp; Wolf, G (2009). The pharmacokinetics of the lymphotropic nanoparticle MRI contrast agent ferumoxtran-10. <i>Cancer biomarkers : section A of Disease markers</i> 5(2) 69–73. DOI:<a href=\"https://doi.org/10.3233/CBM-2009-0579\">10.3233/CBM-2009-0579</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/19414923/\">https://pubmed.ncbi.nlm.nih.gov/19414923</a></p></li><li><p>Shahin, HI, et al., &amp; Chablani, L (2019). Design and evaluation of novel inhalable sildenafil citrate spray-dried microparticles for pulmonary arterial hypertension. <i>Journal of controlled release : official journal of the Controlled Release Society</i> 302 126–139. DOI:<a href=\"https://doi.org/10.1016/j.jconrel.2019.03.029\">10.1016/j.jconrel.2019.03.029</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/30940497/\">https://pubmed.ncbi.nlm.nih.gov/30940497</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end SodiumCitrate;
